RSLS - ReShape Lifesciences - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $-306068.75. This is a potential upside of $-306072.67 (-7807976.28%) from yesterday's end of day stock price of $3.92.

ReShape Lifesciences's activity chart (see below) currently has 7 price targets and 7 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 85% with an average time for these price targets to be met of 92 days.

Most recent stock forecast was given by ANTHONY VENDETTI from MAXIM GROUP on 17-Jul-2024. First documented stock forecast 31-Oct-2016.

Best performing analysts who are covering RSLS - ReShape Lifesciences:

Kyle Rose Rick Wise Anthony Vendetti Ben Haynor David Solomon

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 17-Jul-2024

$290000

1 years 8 months 23 days ago
(17-Jul-2024)

2/2 (100%)

$-107297.22 (-27.01%)

35

$126875

$126859.32 (809051.81%)

$337125

3 years 7 months 23 days ago
(17-Aug-2022)

1/4 (25%)

$58.89 (0.05%)

13

Hold Since 22-May-2019

$326250

$326234.31 (2080576.00%)

$326250

6 years 10 months 18 days ago
(22-May-2019)

2/2 (100%)

$-673750 (-67.38%)

86

Hold Since 26-Feb-2019

$598125

$598109.31 (3814472.75%)

7 years 1 months 14 days ago
(26-Feb-2019)

1/1 (100%)

$-401875 (-40.19%)

149

Hold Since 03-Jan-2019

$652500

$652484.31 (4161252.00%)

$543750

7 years 1 months 15 days ago
(25-Feb-2019)

2/2 (100%)

$-347500 (-34.75%)

177

Show more analysts

Please expand the browser size to see the chart

What is RSLS (ReShape Lifesciences) average time for price targets to be met?

On average it took 92 days on average for the stock forecasts to be realized with a an average price target met ratio 85

Which analyst has the current highest performing score on RSLS (ReShape Lifesciences) with a proven track record?

KYLE ROSE

Which analyst has the current lower performing score on RSLS (ReShape Lifesciences) with a proven track record?

DAVID SOLOMON

Which analyst has the most public recommendations on RSLS (ReShape Lifesciences)?

Kyle Rose works at CANACCORD and has 20 price targets and 13 ratings on RSLS

Which analyst is the currently most bullish on RSLS (ReShape Lifesciences)?

Rick Wise with highest potential upside - $652484.31

Which analyst is the currently most reserved on RSLS (ReShape Lifesciences)?

Anthony Vendetti with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?